. Author manuscript; available in PMC: 2014 Nov 13.

Published in final edited form as: Mod Pathol. 2014 Jan 17;27(9):1281–1287. doi: 10.1038/modpathol.2013.239

Table 2. Patients with and without tumor deposits following neoadjuvant chemoradiation.

	Neoadjuvant chemoradiation +/tumor deposit + patients (n = 23)	Neoadjuvant chemoradiation + /tumor deposit − Patients (n = 87)	P-value
Lymph node Involvement	13/23 (57%)	28/86 (33%)	0.035
Perineural invasion	6/23 (26%)	4/85 (4%)	0.002
Lymphovascular invasion	6/22 (27%)	10/85 (12%)	0.069
Pretreatment stage T3/T4^a	12/12 (100%)	37/43 (86%)	0.170
Treatment response grade 0–1	5/23 (22%)	29/87 (33%)	0.285
5-Year local recurrence rate	19%	10%	0.092
5-Year distant metastases rate	51%	30%	0.006
Overall survival (years)
Median survival	3.1	11.2	0.027
1-Year survival	86%	92%

Determined by endoscopic ultrasound.